These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36753296)

  • 1. Serotonin 4 Receptor Brain Binding in Major Depressive Disorder and Association With Memory Dysfunction.
    Köhler-Forsberg K; Dam VH; Ozenne B; Sankar A; Beliveau V; Landman EB; Larsen SV; Poulsen AS; Ip CT; Jørgensen A; Meyer M; Stenbæk DS; Eiberg HRL; Madsen J; Svarer C; Jørgensen MB; Frokjaer VG; Knudsen GM
    JAMA Psychiatry; 2023 Apr; 80(4):296-304. PubMed ID: 36753296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Familial risk for major depression is associated with lower striatal 5-HT₄ receptor binding.
    Madsen K; Torstensen E; Holst KK; Haahr ME; Knorr U; Frokjaer VG; Brandt-Larsen M; Iversen P; Fisher PM; Knudsen GM
    Int J Neuropsychopharmacol; 2014 Oct; 18(1):. PubMed ID: 25522384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between brain serotonin 4 receptor binding and reactivity to emotional faces in depressed and healthy individuals.
    Sankar A; Ozenne B; Dam VH; Svarer C; Jørgensen MB; Miskowiak KW; Frokjaer VG; Knudsen GM; Fisher PM
    Transl Psychiatry; 2023 May; 13(1):165. PubMed ID: 37169780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress Hormone Dynamics Are Coupled to Brain Serotonin 4 Receptor Availability in Unmedicated Patients With Major Depressive Disorder: A NeuroPharm Study.
    Vulpius GM; Köhler-Forsberg K; Ozenne B; Larsen SV; Nasser A; Svarer C; Gillings N; Keller SH; Jørgensen MB; Knudsen GM; Frokjaer VG
    Int J Neuropsychopharmacol; 2023 Sep; 26(9):639-648. PubMed ID: 37542733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sexual health and serotonin 4 receptor brain binding in unmedicated patients with depression-a NeuroPharm study.
    Rasmussen AL; Larsen SV; Ozenne B; Köhler-Forsberg K; Stenbæk DS; Jørgensen MB; Giraldi A; Frokjaer VG
    Transl Psychiatry; 2023 Jul; 13(1):247. PubMed ID: 37414758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral serotonin 4 receptors and amyloid-β in early Alzheimer's disease.
    Madsen K; Neumann WJ; Holst K; Marner L; Haahr MT; Lehel S; Knudsen GM; Hasselbalch SG
    J Alzheimers Dis; 2011; 26(3):457-66. PubMed ID: 21673407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hot and cold cognitive disturbances in antidepressant-free patients with major depressive disorder: a NeuroPharm study.
    Dam VH; Stenbæk DS; Köhler-Forsberg K; Ip C; Ozenne B; Sahakian BJ; Knudsen GM; Jørgensen MB; Frokjaer VG
    Psychol Med; 2021 Oct; 51(14):2347-2356. PubMed ID: 32317043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The 5-HT4 receptor levels in hippocampus correlates inversely with memory test performance in humans.
    Haahr ME; Fisher P; Holst K; Madsen K; Jensen CG; Marner L; Lehel S; Baaré W; Knudsen G; Hasselbalch S
    Hum Brain Mapp; 2013 Nov; 34(11):3066-74. PubMed ID: 22736538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High brain serotonin levels in migraine between attacks: A 5-HT
    Deen M; Hansen HD; Hougaard A; Nørgaard M; Eiberg H; Lehel S; Ashina M; Knudsen GM
    Neuroimage Clin; 2018; 18():97-102. PubMed ID: 29387527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Migraine is associated with high brain 5-HT levels as indexed by 5-HT
    Deen M; Hougaard A; Hansen HD; Svarer C; Eiberg H; Lehel S; Knudsen GM; Ashina M
    Cephalalgia; 2019 Apr; 39(4):526-532. PubMed ID: 30089402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predicting Treatment Outcome in Major Depressive Disorder Using Serotonin 4 Receptor PET Brain Imaging, Functional MRI, Cognitive-, EEG-Based, and Peripheral Biomarkers: A NeuroPharm Open Label Clinical Trial Protocol.
    Köhler-Forsberg K; Jorgensen A; Dam VH; Stenbæk DS; Fisher PM; Ip CT; Ganz M; Poulsen HE; Giraldi A; Ozenne B; Jørgensen MB; Knudsen GM; Frokjaer VG
    Front Psychiatry; 2020; 11():641. PubMed ID: 32792991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent anxiety in patients with major depression and cerebral serotonin 4 receptor binding. A NeuroPharm-1 study.
    Köhler-Forsberg K; Ozenne B; Larsen SV; Poulsen AS; Landman EB; Dam VH; Ip CT; Jørgensen A; Svarer C; Knudsen GM; Frokjaer VG; Jørgensen MB
    Transl Psychiatry; 2022 Jul; 12(1):273. PubMed ID: 35821015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between the loudness dependence of auditory evoked potential, serotonergic neurotransmission and treatment outcome in patients with depression.
    Ip CT; Ganz M; Ozenne B; Olbrich S; Beliveau V; Dam VH; Köhler-Forsberg K; Jørgensen MB; Frøkjær VG; Knudsen GM
    Eur Neuropsychopharmacol; 2023 May; 70():32-44. PubMed ID: 36863106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain serotonin 4 receptor binding is inversely associated with verbal memory recall.
    Stenbæk DS; Fisher PM; Ozenne B; Andersen E; Hjordt LV; McMahon B; Hasselbalch SG; Frokjaer VG; Knudsen GM
    Brain Behav; 2017 Apr; 7(4):e00674. PubMed ID: 28413715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain serotonin 1A receptor binding as a predictor of treatment outcome in major depressive disorder.
    Miller JM; Hesselgrave N; Ogden RT; Zanderigo F; Oquendo MA; Mann JJ; Parsey RV
    Biol Psychiatry; 2013 Nov; 74(10):760-7. PubMed ID: 23664414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol, moderated by age, is associated with antidepressant treatment outcome and memory improvement in Major Depressive Disorder: A retrospective analysis.
    Jain FA; Connolly CG; Reus VI; Meyerhoff DJ; Yang TT; Mellon SH; Mackin S; Hough CM; Morford A; Wolkowitz OM
    Psychoneuroendocrinology; 2019 Nov; 109():104386. PubMed ID: 31382170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of Striatal Dopamine Transporter Binding in Individuals With Major Depressive Disorder: In Vivo Positron Emission Tomography and Postmortem Evidence.
    Pizzagalli DA; Berretta S; Wooten D; Goer F; Pilobello KT; Kumar P; Murray L; Beltzer M; Boyer-Boiteau A; Alpert N; El Fakhri G; Mechawar N; Vitaliano G; Turecki G; Normandin M
    JAMA Psychiatry; 2019 Aug; 76(8):854-861. PubMed ID: 31042280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of endogenous opioid emotion regulation circuitry in major depression in women.
    Kennedy SE; Koeppe RA; Young EA; Zubieta JK
    Arch Gen Psychiatry; 2006 Nov; 63(11):1199-208. PubMed ID: 17088500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality.
    Miller JM; Brennan KG; Ogden TR; Oquendo MA; Sullivan GM; Mann JJ; Parsey RV
    Neuropsychopharmacology; 2009 Sep; 34(10):2275-84. PubMed ID: 19458612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior.
    Castello J; LeFrancois B; Flajolet M; Greengard P; Friedman E; Rebholz H
    Mol Psychiatry; 2018 Apr; 23(4):872-882. PubMed ID: 29158580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.